| 摘要 |
PCT No. PCT/JP95/02183 Sec. 371 Date Apr. 17, 1997 Sec. 102(e) Date Apr. 17, 1997 PCT Filed Oct. 24, 1995 PCT Pub. No. WO96/12495 PCT Pub. Date May 2, 1996A transdermal administration preparation containing a 9-aminocyclopenta(b)quinoline, preferably 9-amino-2, 3,5,6,7,8-hexahydro-1H-cyclopentane(b)quinoline or its hydrochloride, as an active ingredient and the following transdermal absorption enhancer, that is, at least one compound selected from the group consisting of fatty acids, fatty acid esters, and alcohols, preferably the glyceride of a saturated fatty acid having 6 to 12 carbon atoms.
|
